+254745601747

info@clinicalmedhub.com

Nairobi, Kenya.

Duloxetine - Drug Details

Duloxetine (Cymbalta)

Classification
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Mechanism of Action
Indications
Depression, anxiety, neuropathic pain
Dosage and Administration
30-60 mg once daily
Forms
Capsule
Side Effects
Nausea, dry mouth, fatigue, dizziness
Contraindications
Concurrent use with MAO inhibitors
Interactions
Increased risk of serotonin syndrome with other serotonergic agents
Precautions
Monitor for worsening depression or suicidal thoughts
Pharmacokinetics
Absorbed in the intestines, metabolized in the liver, excreted in urine
Pharmacodynamics
Improves mood and reduces pain perception
Storage Requirements
Store at room temperature, protect from light and moisture
Patient Counselling
Swallow the capsule whole, do not chew or crush
Back to List